Guru Ownership Trend
Guru Analysis for Pliant Therapeutics, Inc. (PLRX)
Pliant Therapeutics, Inc. (PLRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.4 M.
Top institutional holders include Renaissance Technologies (RenTech) and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $193,858.41 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 10.6%. Conversely, Steven Cohen reduced exposure by 57.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Pliant Therapeutics, Inc. (PLRX)
Major holders include Renaissance Technologies (RenTech) ($2.34 M), Paul Tudor Jones ($33,891), Steven Cohen ($22,883). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.1 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $193,858.41, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited PLRX. The total reported sell value was $30,758.04.
Yes, 0 managers opened new positions in PLRX, and 1 increased their existing holdings. The total reported buy value was $224,616.45.